Generic AI tools retrieve fragments and hope. Viore is built for knowledge where the wrong answer has a cost — and the right one has to be defensible.
Find the answer, map the connections, follow the pathway, share the proof.
Get trusted answers with cited evidence, confidence scores, and key moments.
View surfaceStart GLP-1 therapy low and titrate. Most patients achieve glycemic control with 0.25–1.0 mg weekly. Higher doses improve effect sizes up to ~1.2% A1C.
Map concepts and uncover relationships across studies, guidelines, and outcomes.
View surface
Step-by-step clinical and operational pathways with evidence, audio, and summaries.
View surfaceAn evidence-based approach to initiating and titrating GLP-1 therapy with safety checkpoints and monitoring.
View full pathway →Create reviewable knowledge assets, move through review, and share with control.
View surfaceExperts don't reason in 500-token windows. They reason in claims, sources, and consequences.
Judging chunks ignores how experts think—so agreement collapses.
Evaluative Fingerprints is our open research on LLM-as-judge reliability.
Near-zero inter-judge agreement (α = 0.042) sits alongside high within-judge stability (ICC up to 0.872). That result changed how we think about trust, grounding, and retrieval.
Viore is in private pilot with a curated cohort. We're selective about who we take next, and honest about who we're not for.